Other Assets, Noncurrent in USD of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of noncurrent assets classified as other.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Other Assets, Noncurrent for the quarter ending 30 Jun 2023 was $357K, a 23.4% decline year-over-year.

Other Assets, Noncurrent, Quarterly (USD)

Other Assets, Noncurrent, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Other Assets, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$357K	-$109K	-23.4%	30 Jun 2023	10-Q	09 Aug 2023
Q1 2023	$380K			31 Mar 2023	10-Q	11 May 2023
Q4 2022	$339K	-$191K	-36%	31 Dec 2022	10-Q	09 Aug 2023
Q2 2022	$466K			30 Jun 2022	6-K	29 Aug 2022
Q4 2021	$530K	-$94K	-15.1%	31 Dec 2021	10-K	30 Mar 2023
Q4 2020	$624K			31 Dec 2020	20-F	26 Apr 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.